Recent Progress of Small Molecule Menin–MLL Interaction Inhibitors as Therapeutic Agents for Acute Leukemia
Por um escritor misterioso
Descrição
Recent Progress of Small Molecule Menin–MLL Interaction Inhibitors as Therapeutic Agents for Acute Leukemia
Pharmacologic Inhibition of the Menin-MLL Interaction Blocks Progression of MLL Leukemia In Vivo - ScienceDirect
Designed to Kill: Novel Menin-MLL Inhibitors Target MLL-Rearranged Leukemia - ScienceDirect
Covalent and noncovalent constraints yield a figure eight-like conformation of a peptide inhibiting the menin-MLL interaction - ScienceDirect
Recent Progress of Small Molecule Menin–MLL Interaction Inhibitors as Therapeutic Agents for Acute Leukemia
Frontiers Drug Repurposing for Targeting Acute Leukemia With KMT2A (MLL)—Gene Rearrangements
Recent Progress of Small Molecule Menin–MLL Interaction Inhibitors as Therapeutic Agents for Acute Leukemia
Therapeutic implications of menin inhibition in acute leukemias
Molecules, Free Full-Text
A molecular switch between mammalian MLL complexes dictates response to Menin-MLL inhibition
Characterization of the menin-MLL inhibitors.(a) Structures and IC50
Inhibitors of the Menin-Mixed Lineage Leukemia (MLL) Interaction - Probe Reports from the NIH Molecular Libraries Program - NCBI Bookshelf
PDF] Pharmacologic inhibition of the Menin-MLL interaction blocks progression of MLL leukemia in vivo.
Recent Progress of Small Molecule Menin–MLL Interaction Inhibitors as Therapeutic Agents for Acute Leukemia
de
por adulto (o preço varia de acordo com o tamanho do grupo)
